Clinical Study

Aggressive versus Low Dose Inhibition of the Renin-Angiotensin System for the Treatment of Microalbuminuria in Type 2 Diabetic Patients: A Pilot Study

Figure 2

Responses after randomization; (a) albumin : creatinine ratio; (b) visit systolic BP; (c) visit diastolic BP; (d) HbA1c level; (e) estimated glomerular filtration rate; (f) right CIMT; (g) left CIMT; (h) reactive hyperemia-induced peripheral arterial tonometry; (i) nitroglycerine-induced peripheral arterial tonometry; (j) highly sensitive C-reactive protein. The number of subjects followed at each three month interval in the aggressive- and low-dose groups, respectively, were three months-11 and 12; six months-9 and 11, nine months-8 and 9, 12 months 6 and 6; 15 months-6 and 6; and 18 months-5 and 5. Standard : low dose. Data in graphs (a), (b), (c), and (e) were measured monthly but shown bimonthly for ease of presentation.
696124.fig.002a
(a)
696124.fig.002b
(b)
696124.fig.002c
(c)
696124.fig.002d
(d)
696124.fig.002e
(e)
696124.fig.002f
(f)
696124.fig.002g
(g)
696124.fig.002h
(h)
696124.fig.002i
(i)
696124.fig.002j
(j)